Abbisko Cayman Limited Founder and CEO Increases Shareholding

Key Highlights

• Dr. Xu Yao-Chang, Founder, Executive Director, CEO, and Chairman of Abbisko Cayman Limited, has increased his stake in the company.
• Dr. Xu purchased 45,000 ordinary shares on the open market on March 3, 2026 at an average price of HK\$11.26 per share.
• This purchase represents approximately 0.01% of the company’s total issued shares.
• Following this transaction, Dr. Xu now holds a total of 81,769,968 shares, equivalent to 12.02% of Abbisko’s total issued shares.

Details of the Transaction

On March 3, 2026, Dr. Xu Yao-Chang, the founder and key executive of Abbisko Cayman Limited, acquired 45,000 shares of the company in the open market. The average purchase price was HK\$11.26 per share. This move further consolidates Dr. Xu’s position as a major shareholder, bringing his total ownership to 12.02% of the company’s issued share capital.

Implications for Investors

• Leadership Confidence: Dr. Xu’s decision to increase his shareholding demonstrates his confidence in Abbisko’s future business prospects and growth trajectory. This is often interpreted positively by the market, as it signals the alignment of the chief executive’s interests with those of other shareholders.
• Potential for Further Increases: Dr. Xu has indicated that, subject to regulatory requirements and market conditions, he does not rule out the possibility of further increasing his stake in the company. This could be seen as a continued sign of confidence and may support the share price, depending on market sentiment.
• Regulatory Compliance: The company has confirmed that the increase in shareholding was conducted in full compliance with all relevant legal and regulatory requirements, including Rule 8.08 of the Listing Rules and the Model Code for Securities Transactions by Directors of Listed Issuers. Importantly, the company continues to maintain a sufficient public float, as required by the Hong Kong Stock Exchange.
• Price Sensitivity: Shareholder and potential investors should note that insider buying, especially by a key executive, is generally considered price sensitive information and could have a positive impact on market perception of the company.

Board Composition

As of the date of this announcement, the Board consists of:

• Executive Directors: Dr. Xu Yao-Chang, Dr. Yu Hongping, and Dr. Ji Jing
• Independent Non-Executive Directors: Dr. Sun Piaoyang, Mr. Sun Hongbin, and Ms. Chui Hoi Yam

Cautionary Note to Investors

The company advises all shareholders and potential investors to exercise caution when dealing in the securities of Abbisko Cayman Limited, as share prices may be influenced by this insider activity and other market factors.

Disclaimer: The above article is for informational purposes only and does not constitute investment advice. Investors are advised to conduct their own research or consult professional advisors before making investment decisions. The company and the author of this article accept no liability for any loss arising from reliance on the information provided herein.

View ABBISKO-B Historical chart here